Subscribe To
ALX Oncology Announces Proposed Public Offering
SOUTH SAN FRANCISCO, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today announced that it has commenced an underwritten public offering of its common stock and pre-funded warrants. All shares of common stock […] The post ALX Oncology Announces Proposed Public Offering appeared first on ForexTV...
Read More
Posted: Oct 4 2023, 20:10
Author Name: forextv
Views: 112914